We are live on ! Find out more
IBDH

iShares iBonds Dec 2018 Term Corporate ETF

Delisted

IBDH was delisted on the 17th of December, 2018.

1 hedge funds and large institutions have $0 invested in iShares iBonds Dec 2018 Term Corporate ETF in 2018 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 69 closing their positions.

New
Increased
Maintained
Reduced
Closed

52.74% less ownership

Funds ownership: 52.74% → 0% (-53%)

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 69

99% less funds holding

Funds holding: 70 → 1 (-69)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $219M → $0 (-$219M)

Holders
1
Holders Change
-69
Holders Change %
-98.57%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
69
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IBDH Hedge Fund Activity: Q4 2018 in Review

1 of the 4,505 institutional investors tracked by Wall St. Rank reported a position in iShares iBonds Dec 2018 Term Corporate ETF (IBDH) for Q4 2018, worth a combined $0 — down 100% from $219M a quarter earlier.

Sellers outnumbered buyers: 69 funds closed out of IBDH and 1 opened new positions — a net loss of 68 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Ameriprise, exiting entirely with an estimated $27.1M sold.

  • 1 institutional investor held iShares iBonds Dec 2018 Term Corporate ETF (IBDH) as of Q4 2018, down from 70 in Q3 2018.
  • Funds reported $0 of iShares iBonds Dec 2018 Term Corporate ETF stock for Q4 2018, down 100% quarter-over-quarter.
  • 1 fund opened new iShares iBonds Dec 2018 Term Corporate ETF positions in Q4 2018 and 69 closed out, a net change of -68 holders.
  • The largest iShares iBonds Dec 2018 Term Corporate ETF seller in Q4 2018 was Ameriprise, an estimated $27.1M sold.

Based on aggregated 13F filings for Q4 2018.